Feldwisch J - Search Results

1

Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [⁶⁸Ga]Ga-ABY-025 tracer.

Jussing E, Ferrat M, Moein MM, Alfredéen H, Tegnebratt T, Bratteby K, Samén E, Feldwisch J, Altena R, Axelsson R, Tran TA. Jussing E, et al. Among authors: feldwisch j. EJNMMI Radiopharm Chem. 2023 Nov 22;8(1):41. doi: 10.1186/s41181-023-00226-y. EJNMMI Radiopharm Chem. 2023. PMID: 37991639 Free PMC article.

2

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors.

Orlova A, Tolmachev V, Pehrson R, Lindborg M, Tran T, Sandström M, Nilsson FY, Wennborg A, Abrahmsén L, Feldwisch J. Orlova A, et al. Among authors: feldwisch j. Cancer Res. 2007 Mar 1;67(5):2178-86. doi: 10.1158/0008-5472.CAN-06-2887. Cancer Res. 2007. PMID: 17332348

3

99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule.

Engfeldt T, Tran T, Orlova A, Widström C, Feldwisch J, Abrahmsen L, Wennborg A, Karlström AE, Tolmachev V. Engfeldt T, et al. Among authors: feldwisch j. Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1843-53. doi: 10.1007/s00259-007-0474-6. Epub 2007 Jun 13. Eur J Nucl Med Mol Imaging. 2007. PMID: 17565496

4

(99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors.

Tran T, Engfeldt T, Orlova A, Sandström M, Feldwisch J, Abrahmsén L, Wennborg A, Tolmachev V, Karlström AE. Tran T, et al. Among authors: feldwisch j. Bioconjug Chem. 2007 Nov-Dec;18(6):1956-64. doi: 10.1021/bc7002617. Epub 2007 Oct 19. Bioconjug Chem. 2007. PMID: 17944527

5

Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake.

Ekblad T, Tran T, Orlova A, Widström C, Feldwisch J, Abrahmsén L, Wennborg A, Karlström AE, Tolmachev V. Ekblad T, et al. Among authors: feldwisch j. Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2245-55. doi: 10.1007/s00259-008-0845-7. Epub 2008 Jul 2. Eur J Nucl Med Mol Imaging. 2008. PMID: 18594815

6

Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody molecules.

Tran TA, Ekblad T, Orlova A, Sandström M, Feldwisch J, Wennborg A, Abrahmsén L, Tolmachev V, Eriksson Karlström A. Tran TA, et al. Among authors: feldwisch j. Bioconjug Chem. 2008 Dec;19(12):2568-76. doi: 10.1021/bc800244b. Bioconjug Chem. 2008. PMID: 19035668

7

Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.

Ahlgren S, Wållberg H, Tran TA, Widström C, Hjertman M, Abrahmsén L, Berndorff D, Dinkelborg LM, Cyr JE, Feldwisch J, Orlova A, Tolmachev V. Ahlgren S, et al. Among authors: feldwisch j. J Nucl Med. 2009 May;50(5):781-9. doi: 10.2967/jnumed.108.056929. Epub 2009 Apr 16. J Nucl Med. 2009. PMID: 19372467 Free article.

8

Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer.

Alhuseinalkhudhur A, Lubberink M, Lindman H, Tolmachev V, Frejd FY, Feldwisch J, Velikyan I, Sörensen J. Alhuseinalkhudhur A, et al. Among authors: feldwisch j. EJNMMI Res. 2020 Mar 23;10(1):21. doi: 10.1186/s13550-020-0603-9. EJNMMI Res. 2020. PMID: 32201920 Free PMC article.

9

[⁶⁸Ga]ABY-028: an albumin-binding domain (ABD) protein-based imaging tracer for positron emission tomography (PET) studies of altered vascular permeability and predictions of albumin-drug conjugate transport.

Jussing E, Lu L, Grafström J, Tegnebratt T, Arnberg F, Rosik HW, Wennborg A, Holmin S, Feldwisch J, Stone-Elander S. Jussing E, et al. Among authors: feldwisch j. EJNMMI Res. 2020 Sep 22;10(1):106. doi: 10.1186/s13550-020-00694-2. EJNMMI Res. 2020. PMID: 32960353 Free PMC article.

10

Human Epidermal Growth Factor Receptor 2-Targeting [⁶⁸Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer.

Alhuseinalkhudhur A, Lindman H, Liss P, Sundin T, Frejd FY, Hartman J, Iyer V, Feldwisch J, Lubberink M, Rönnlund C, Tolmachev V, Velikyan I, Sörensen J. Alhuseinalkhudhur A, et al. Among authors: feldwisch j. J Nucl Med. 2023 Sep;64(9):1364-1370. doi: 10.2967/jnumed.122.265364. Epub 2023 Jul 13. J Nucl Med. 2023. PMID: 37442602 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page